Eugenol‐Derived Piperazine Mannich Bases as Selective Inhibitors of Mayaro Virus: In Vitro Antiviral Evaluation and Mechanistic Insights
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Adriana Cotta Cardoso Reis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy School, Federal University of Ouro Preto, Ouro Preto, Brazil. Hauptthemen laut MEDLINE: Antiviral Agents, Alphavirus, Eugenol, Piperazines. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FundaÇÃo de Amparo À Pesquisa do Estado de Minas Gerais, Conselho Nacional de Desenvolvimento CientÍfico e TecnolÓgico, Universidade Federal de Ouro Preto.
Abstract (Originalsprache)
Arboviruses represent an ongoing global health challenge, particularly in tropical regions where diseases caused by Chikungunya virus (CHIKV) and Mayaro virus (MAYV) continue to emerge. Given the absence of licensed antiviral therapies, the identification of effective small molecules remains critical. This study evaluated sixteen eugenol‐ and dihydroeugenol‐derived piperazine Mannich bases for antiviral activity against CHIKV, MAYV, and Zika virus (ZIKV) in Vero cells. Cytotoxicity was assessed using the MTT assay, and antiviral activity was quantified through median effective concentration (EC 50 ) and selectivity index (SI) values. Time‐dependent cytopathic effect inhibition, plaque reduction assays, virucidal assays and docking were performed to characterize the mechanism of action. Three compounds ( D3 , D7 , and E7 ) exhibited selective antiviral activity. Notably, compound D7 demonstrated low‐micromolar anti‐MAYV inhibition (EC 50 = 14.43 μM; SI > 16.6), surpassing ribavirin by more than thirty‐fold in relative potency. Time‐dependent assays revealed progressive viral titer reductions of up to 3 log 10 PFU/mL over 48 h. Virucidal assays confirmed that D7 does not directly inactivate viral particles. These findings identify D7 as a promising antiviral lead compound and provide a foundation for further mechanistic, optimization, and in vivo studies aimed at developing anti‐alphavirus therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacy School, Federal University of Ouro Preto, Ouro Preto, Brazil.
- Department of Pharmaceutical Sciences, Federal University of Alfenas, Alfenas, Brazil.
ORCID-Profile: Adriana Cotta Cardoso Reis, Saulo Fehelberg Pinto Braga, Thiago Belarmino de Souza, Diogo Teixeira Carvalho, Geraldo Célio Brandão
Förderung
- FundaÇÃo de Amparo À Pesquisa do Estado de Minas Gerais
- Conselho Nacional de Desenvolvimento CientÍfico e TecnolÓgico
- Universidade Federal de Ouro Preto
Zitieren
APA
Reis, A. C. C., Silva, A. L. S. D., Portruneli, C., Silva, A. V. P., Braga, S. F. P., Lapa, I. R., Souza, T. B., Franco, L. L., Carvalho, D. T., & Brandão, G. C. (2026). Eugenol‐Derived Piperazine Mannich Bases as Selective Inhibitors of Mayaro Virus: In Vitro Antiviral Evaluation and Mechanistic Insights. Journal of Medical Virology. https://doi.org/10.1002/jmv.71158
Vancouver
Reis ACC, Silva ALSD, Portruneli C, Silva AVP, Braga SFP, Lapa IR, et al. Eugenol‐Derived Piperazine Mannich Bases as Selective Inhibitors of Mayaro Virus: In Vitro Antiviral Evaluation and Mechanistic Insights. Journal of Medical Virology. 2026. doi:10.1002/jmv.71158
BibTeX
@article{Reis2026,
author = {Reis, Adriana Cotta Cardoso and Silva, Amália Luíza de Sousa da and Portruneli, Camila and Silva, Augusto Vieira Pontes and Braga, Saulo Fehelberg Pinto and Lapa, Igor Rodrigues and Souza, Thiago Belarmino de and Franco, Lucas Lopardi and Carvalho, Diogo Teixeira and Brandão, Geraldo Célio},
title = {Eugenol‐Derived Piperazine Mannich Bases as Selective Inhibitors of Mayaro Virus: In Vitro Antiviral Evaluation and Mechanistic Insights},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71158}
}
EUVIMED